Judith Collins

4.7k total citations · 2 hit papers
18 papers, 1.7k citations indexed

About

Judith Collins is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Judith Collins has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Genetics and 5 papers in Surgery. Recurrent topics in Judith Collins's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (12 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Judith Collins is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (12 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Judith Collins collaborates with scholars based in United States, Austria and Australia. Judith Collins's co-authors include Brian G. Feagan, Richard Strauß, Jewel Johanns, Colleen Marano, William J. Sandborn, Paul Rutgeerts, Omoniyi J. Adedokun, Jean‐Frédéric Colombel, Gunnar Järnerot and Peter R. Gibson and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Judith Collins

17 papers receiving 1.6k citations

Hit Papers

Subcutaneous Golimumab Induces Clinical Response and Remi... 2013 2026 2017 2021 2013 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Collins United States 9 1.3k 1.0k 357 354 178 18 1.7k
Benjamin Pariente France 23 1.4k 1.1× 1.1k 1.0× 420 1.2× 665 1.9× 155 0.9× 88 1.8k
Deborah Woodworth United States 7 1.1k 0.9× 794 0.8× 313 0.9× 339 1.0× 202 1.1× 37 1.5k
Sara Onali Italy 26 1.1k 0.8× 709 0.7× 269 0.8× 514 1.5× 190 1.1× 68 1.5k
Eric Vasiliauskas United States 12 1.0k 0.8× 823 0.8× 350 1.0× 332 0.9× 69 0.4× 27 1.4k
Mark R. Fleisher United States 10 674 0.5× 520 0.5× 429 1.2× 220 0.6× 118 0.7× 17 1.2k
Émilie Del Tedesco France 18 1.5k 1.2× 1.3k 1.3× 569 1.6× 390 1.1× 75 0.4× 40 1.8k
Hans Verbaan Sweden 19 905 0.7× 1.6k 1.6× 164 0.5× 400 1.1× 84 0.5× 44 2.0k
Masakazu Nagahori Japan 20 912 0.7× 601 0.6× 184 0.5× 466 1.3× 218 1.2× 68 1.4k
Jeroen M. Jansen Netherlands 19 1.2k 1.0× 944 0.9× 442 1.2× 362 1.0× 85 0.5× 48 1.5k
G. D’Haens Netherlands 12 985 0.8× 851 0.8× 211 0.6× 380 1.1× 63 0.4× 37 1.2k

Countries citing papers authored by Judith Collins

Since Specialization
Citations

This map shows the geographic impact of Judith Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Collins more than expected).

Fields of papers citing papers by Judith Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Collins. The network helps show where Judith Collins may publish in the future.

Co-authorship network of co-authors of Judith Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Collins. A scholar is included among the top collaborators of Judith Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Collins. Judith Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Reinisch, Walter, Peter G. Gibson, William J. Sandborn, et al.. (2018). Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension. Journal of Crohn s and Colitis. 12(9). 1053–1066. 23 indexed citations
2.
Gibson, Peter G., Brian G. Feagan, William J. Sandborn, et al.. (2016). Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year. Clinical and Translational Gastroenterology. 7(4). e168–e168. 34 indexed citations
3.
Reinisch, Walter, Peter G. Gibson, William J. Sandborn, et al.. (2016). Mo1790 Safety, Efficacy, and Pharmacokinetics of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-SC Long term Extension. Gastroenterology. 150(4). S776–S777. 1 indexed citations
4.
Keyashian, Kian, et al.. (2015). Dysplasia in Inflammatory Bowel Disease: A Review of a US Endoscopic Database. The American Journal of Gastroenterology. 110. S800–S800. 1 indexed citations
5.
Reinisch, Walter, Peter G. Gibson, William J. Sandborn, et al.. (2014). OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension. Journal of Crohn s and Colitis. 8. S6–S7. 1 indexed citations
6.
Sandborn, William J., Brian G. Feagan, Colleen Marano, et al.. (2013). Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 146(1). 85–95. 701 indexed citations breakdown →
7.
Sandborn, William J., Brian G. Feagan, Colleen Marano, et al.. (2013). Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 146(1). 96–109.e1. 549 indexed citations breakdown →
9.
Sandborn, William J., Walter Reinisch, Brian G. Feagan, et al.. (2013). Early Responses in Patient-reported Outcomes Are Predictors for Mucosal Healing in Patients with Moderately to Severely Active Ulcerative Colitis Treated with Golimumab: Results from PURSUIT SC Induction. The American Journal of Gastroenterology. 108. S519–S519. 1 indexed citations
10.
Feagan, Brian G., Peter G. Gibson, Colleen Marano, et al.. (2012). Impact of Golimumab SC on Disease Specific and Generic HRQoL in Patients With Moderately to Severely Active UC: PURSUIT-SC Induction. Inflammatory Bowel Diseases. 18. S43–S43. 2 indexed citations
11.
Sandborn, William J., Brian Feagan, Colleen Marano, et al.. (2012). Clinical Response Is a Meaningful Endpoint in Ulcerative Colitis Clinical Studies. Inflammatory Bowel Diseases. 18. S26–S27. 3 indexed citations
12.
Anawalt, Bradley D., et al.. (2011). Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1. Inflammatory Bowel Diseases. 17(10). 2122–2129. 46 indexed citations
13.
Collins, Judith, et al.. (2008). Predictors of Pouchitis after Ileal Pouch-Anal Anastomosis: A Retrospective Review. Diseases of the Colon & Rectum. 51(5). 554–560. 75 indexed citations
14.
Sonnenberg, Amnon & Judith Collins. (2006). Vicious circles in inflammatory bowel disease. Inflammatory Bowel Diseases. 12(10). 944–949. 3 indexed citations
15.
16.
Kempton, Christine L., Grover C. Bagby, & Judith Collins. (2001). Ulcerative Colitis Presenting as Purpura Fulminans. Inflammatory Bowel Diseases. 7(4). 319–322. 6 indexed citations
17.
Stolley, Jacqueline M., et al.. (1993). MANAGING THE CARE OF PATIENTS WITH IRREVERSIBLE DEMENTIA DURING HOSPITALIZATION FOR COMORBIDITIES. Nursing Clinics of North America. 28(4). 767–782. 10 indexed citations
18.
Collins, Judith. (1990). Methemoglobinemia as a complication of 20% benzocaine spray for endoscopy. Gastroenterology. 98(1). 211–213. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026